Glutamic acid decarboxylase autoantibodies, zinc transporter 8 autoantibodies, insulin autoantibodies, islet antigen 2 autoantibodies, and islet cell antibodies were all negative.<h4>Conclusion</h4>Anti-PD-1 immunotherapy is effective in cancers refractory to standard chemotherapy. This evidence concerns the gene INS and cancer.